U.S. markets open in 1 hour 4 minutes

HealthEquity, Inc. (HQY)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
51.56-1.72 (-3.23%)
At close: 4:00PM EDT

51.63 +0.07 (0.14%)
Before hours: 7:00AM EDT

Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Price Crosses Moving Average

Price Crosses Moving Average

Previous Close53.28
Open53.13
Bid48.47 x 800
Ask0.00 x 800
Day's Range51.00 - 53.13
52 Week Range34.40 - 88.78
Volume800,030
Avg. Volume930,901
Market Cap3.954B
Beta (5Y Monthly)1.51
PE Ratio (TTM)N/A
EPS (TTM)-0.00
Earnings DateSep 01, 2020 - Sep 08, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est63.08
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Undervalued
39% Est. Return
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • GlobeNewswire

    HealthEquity Announces Closing of Sale of Additional Shares

    DRAPER, Utah, July 15, 2020 -- HealthEquity, Inc. (NASDAQ: HQY) (“HealthEquity” or the “Company”) today announced the closing of the underwritten public offering of an.

  • GlobeNewswire

    HealthEquity Announces Closing of Follow-on Offering

    DRAPER, Utah, July 13, 2020 -- HealthEquity, Inc. (NASDAQ: HQY) (“HealthEquity” or the “Company”), today announced the closing of the underwritten public offering of 4,600,000.

  • GlobeNewswire

    HealthEquity Announces Commencement of Proposed Offering of Common Stock

    HealthEquity intends to use the net proceeds from the offering to free up additional capital for organic and inorganic growth by pre-paying $200 million under its term loan facility, with the remaining proceeds to be used for general corporate purposes, which may include additional pre-payments under its term loan facility and/or potential acquisitions. Wells Fargo Securities, LLC and J.P. Morgan Securities LLC are acting as lead book-running managers for the offering. Goldman Sachs & Co. LLC, and RBC Capital Markets LLC are acting as book-running managers for the offering.